Phibro Animal Health

PAHCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.391 B

$34.29 -3.41%

Close of 7 Aug 2026

Revenue

$1.30B

#1382 by revenue

Earnings

$48.3M

#1592 by earnings

Shares outstanding

40,956,000

Latest filing cover page

P/E ratio

28.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#141ArriVent BioPharmaAVBP$1.44B
#142Oric PharmaceuticalsORIC$1.40B
#143Phibro Animal HealthPAHC$1.39B
#144Lb PharmaceuticalsLBRX$1.38B
#145Xeris BiopharmaXERS$1.37B

Where these numbers come from

Share counts and financials for Phibro Animal Health are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.